Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) will be posting its quarterly earnings results after the market closes on Tuesday, November 7th. Analysts expect Nektar Therapeutics to post earnings of ($0.18) per share for the quarter. Individual that are interested in registering for the company’s earnings conference call can do so using this link. Nektar […]
Related Keywords
United States , , Verition Fund Management , Syntax Advisors , Halbert Hargrove Global Advisors , Life Insurance Co , Nektar Therapeutics Company Profile , Nektar Therapeutics , Get Free Report , Fund Management , Hargrove Global Advisors , Financial Advocates Investment Management , Nektar Therapeutics Daily , Nasdaq Nktr , Nktr , Medical , 64026810 , Earnings ,
comparemela.com © 2020. All Rights Reserved.